NCLAT issues notice in appeal filed by Standard Pharmaceuticals director against Section 7 insolvency admission order.
Appellant disputes Rs 7.41 crore debt claim and argues petition barred by Section 10A of IBC.
Financial creditor JM Financial ARCL maintains debt is higher based on mortgaged property market value.
Tribunal grants time for response filing and lists matter for hearing on November 23, 2026.